About The Cronos Group
The Cronos Group is a publicly listed company based in Toronto (Canada) founded in 2013. It operates as a medicinal cannabis products are produced and supplied by the company. The Cronos Group has raised $137.46 thousand across 4 funding rounds from investors including Canadian Imperial Bank of Commerce, BMO and Altria. The company has 459 employees. Its chief executive is Michael Gorenstein. Its website thecronosgroup.com draws about 13 thousand monthly visits. The Cronos Group offers products and services including Cannabis Products and Branded Goods. Its focus areas include Food and Agriculture, Cannabis Growers and Healthcare.
Company details
The Cronos Group was founded in 2013 and is headquartered in Toronto, Canada. As a licensed producer in the cannabis sector, operations focus on manufacturing and distributing medicinal cannabis and related products. These items are offered under the companys brand across multiple international production and distribution facilities.
- Headquarters Toronto, Canada
- Employees 459
- Stage Public
- SectorsConsumer
- Email••••••••
- Phone•••• ••••
- Website thecronosgroup.com
- Social LinkedIn X Facebook
- Legal Name Cronos Group Inc
- Annual Revenue$149.59 M (USD)27.12as on Dec 31, 2025
- Net Profit-$9.64 M (USD)-123.46as on Dec 31, 2025
- EBITDA-$3.37 M (USD)93.15as on Dec 31, 2025
- Total Equity Funding$137.46K (USD)
in 4 rounds
- Latest Funding Round$1.8B (USD), Post-IPO
Mar 2019
- InvestorsCanadian Imperial Bank of Commerce
& 2 more
- Employee Count459
Products & Services of The Cronos Group
The Cronos Group offers a comprehensive portfolio of products and services, including Cannabis Products and Branded Goods.
Cannabis products are developed and distributed by Cronos Group through research and technology advancements for consumer use
Branded goods are marketed by Cronos Group under various labels to promote reliability and transparency in the industry
Funding Insights of The Cronos Group
The Cronos Group has successfully raised a total of $137.46K across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.8 billion completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $137,460
- Total Rounds 4
- Last Round Post-IPO — $1.8B
- First Round $137,460
(Apr 2014)
- Investors Count 3
All 4 funding rounds of The Cronos Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $1.8B | Post-IPO | – | – | |
| Jan 2019 | $65M | Debt – Conventional | – | – | |
| Aug 2014 | $1.54M | Post-IPO | – | – | – |
| Apr 2014 | $137,460 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in The Cronos Group
The Cronos Group has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, BMO and Altria.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tobacco products are manufactured and distributed by Altria through subsidiaries. | 1919 | altria.com | Richmond, United States | |
BMO is recognized as a leading financial services provider in Canada. | 1817 | bmo.com | Toronto, Canada | |
Commercial banking services are provided to individuals and businesses. | 1867 | cibc.com | Toronto, Canada |
Investor details for The Cronos Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of The Cronos Group
82 people are tracked at The Cronos Group (23 in leadership, 6 in board & advisors, 53 in team); the tracked headcount is 459.
| Name | Role | Group |
|---|---|---|
Michael Gorenstein | CEO & President | Leadership |
Jared Kenost | Senior Director, Technical Accounting & Financial Reporting | Leadership |
Melissa Smith | Director Fp&a | Leadership |
Shannon Buggy | SVP, Global Head of People | Leadership |
Danny Kisliansky | Director Of Finance Transformation | Leadership |
Prosci® Jenifer Laranjeiro | Strategic Human Resources Business Partner | Leadership |
Bianca Nicolescu | Head Of Strategy & Specialty Finance | Leadership |
Anna Shlimak | Chief Financial Officer | Leadership |
Michael Akavan | Deputy General Counsel, Head Of Litigation | Leadership |
Ryan Morgan | Director, Securities Counsel And Assistant Corporate Secretary | Leadership |
Ivan Druzic | Group Creative Director | Leadership |
Jennifer Ellis | Global Head Of Total Rewards | Leadership |
Genna Erway | Global Head Of Talent | Leadership |
John Crough | National Sales Director, Canada | Leadership |
Brandon Cohen | Vice President Sales & Trade Development North America | Leadership |
Alyssa Porter | Director, Trade Marketing | Leadership |
Michelle Circosta | Director - Marketing & Innovation | Leadership |
Alanna Fonseca | Vice President Marketing And Innovation | Leadership |
Kylie Enns | Director, Design & Creative Production - North America | Leadership |
Kriti Sehgal | Director Commercialization And Project Management | Leadership |
62 more people are available in the full profile.
Complete people profiles for The Cronos Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of The Cronos Group
The Cronos Group is a publicly listed company on the TSX with ticker symbol CRON in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 May 2018
- Listed onTSX: CRON
- Listed entityCronos Group Inc
- Exchange sectorHealth technology
- ISINCA22717L1013
- Share price4.54 CAD (-1.73% on the day) · 2026-10-13
- Market capitalisation1,672,594,426.00 CAD
- Price to earnings17.9
- EPS (diluted, trailing year)0.25 CAD
- Volume (last session)63,598
Financials of The Cronos Group
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 204.8M CAD | -13.2M CAD | -4.6M CAD |
| 2024 | 161.1M CAD | 56.3M CAD | -67.4M CAD |
| 2023 | 117.8M CAD | -99.7M CAD | -97.2M CAD |
| 2022 | 112.9M CAD | -219.4M CAD | -118.8M CAD |
| 2021 | 93.3M CAD | -496.6M CAD | -227.6M CAD |
Detailed financial statements for The Cronos Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of The Cronos Group
4 dated milestones of The Cronos Group across 6 years, from founding to its latest funding, stage changes and deals.
- Founded The Cronos Group is founded.
- Funding First funding round of $137K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $1.8B.
Web traffic of The Cronos Group
The website of The Cronos Group (thecronosgroup.com) receives about 13.2K visits a month.
- Monthly visits13.2K
▲ 1.4% vs previous month
Top companies in Cannabis Industry & Retail
10 companies that operate in the same segment as The Cronos Group (Cannabis Industry & Retail), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Comprehensive management and consulting services for marijuana operations are provided. | 2010 | Culver City, California, United States | USD 202.64 M | USD 140.81 M | – | |
Online e-distributor offering cannabis products for medical purposes | 2013 | Leamington, Ontario, Canada | USD 98.25 M | USD 914.37 M | 2,840 | |
Cannabis-related health and wellbeing products are provided nationally. | 2002 | Chicago, Illinois, United States | – | USD 824.73 M | 4,600 | |
Cannabis plants and products services are provided by AWH. | 2014 | Cambridge, Massachusetts, United States | USD 134.83 M | USD 500.58 M | 2,300 | |
Medical cannabis products for sleep disorders are provided. | 2014 | Baltimore, Maryland, United States | USD 30.85 M | – | – | |
Distributor of cannabis based products | 2018 | Boca Raton, Florida, United States | USD 68.2 M | USD 268.3 M | 1,230 | |
Medical marijuana is produced and distributed by Aurora Cannabis. | 2006 | Edmonton, Alberta, Canada | – | USD 230.07 M | 1,100 | |
Cannabis products for health and wellbeing are developed and provided. | 1996 | Chicago, Illinois, United States | USD 120 M | USD 839.91 M | 3,800 | |
Hemp-based cannabinoid products are produced and distributed by Prima. | 2018 | Santa Monica, California, United States | USD 12.48 M | – | – | |
Platform for managing cannabis manufacturing operations is provided. | 1987 | Toronto, Ontario, Canada | – | USD 110.63 M | 388 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about The Cronos Group
Complete news archive for The Cronos Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about The Cronos Group
The Cronos Group was founded in 2013 and raised its 1st funding round 1 year after it was founded.
The Cronos Group is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Michael Gorenstein is the current CEO of The Cronos Group.
The Cronos Group is a funded company, having raised a total of $137.46K across 4 funding rounds to date. The company's 1st funding round was a Seed of $137.46K, raised on Apr 2014.
The Cronos Group has 459 employees.
Annual revenue of The Cronos Group is $149.59M as on Dec 31, 2025.
The Cronos Group was founded in 2013 and is headquartered in Toronto, Canada. As a licensed producer in the cannabis sector, operations focus on manufacturing and distributing medicinal cannabis and related products. These items are offered under the companys brand across multiple international production and distribution facilities.
The Cronos Group offers Cannabis Products and Branded Goods.
Yes, The Cronos Group is publicly traded on TSX under the ticker symbol CRON.
The Cronos Group has 3 investors. Key investors include Canadian Imperial Bank of Commerce, BMO, and Altria.
The Cronos Group operates through The Cronos Group.